Legal Representation
Attorney
Margaret C. McHugh
USPTO Deadlines
Next Deadline
2175 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-07-08)
Due Date
July 08, 2031
Grace Period Ends
January 08, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 8, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 8, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 20, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 20, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 14, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 21, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 14, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 14, 2025 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Apr 14, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 22, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jan 22, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Jan 22, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Nov 29, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 27, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 27, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 30, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 30, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 30, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 30, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 4, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 6, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for immunotherapy and cancer therapy; medical and veterinary preparations for treating immune diseases and cancer; Substances adapted for medical or veterinary use, namely pharmaceutical preparations for treating immune diseases and cancer; Vaccines and medicines for the treatment of cancer, immune diseases, neurodegenerative diseases, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS), and senescence associated diseases being age-related conditions, namely, frailty, osteoporosis, liver steatosis, and cognitive decline; Viral-based immunotherapeutics being pharmaceutical preparations, in particular for the treatment of cancer, immune diseases, neurodegenerative diseases, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, and ALS, and senescence associated diseases being age-related conditions, namely, frailty, osteoporosis, liver steatosis, and cognitive decline
Class 035
Business management, organization and administration; business management of licences for pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; import and export agency services in the field of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; retail store and wholescale store services, and online retail store and wholesale store services, in the field of pharmaceuticals, vaccines and medicines, such as viral- based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases
Class 042
Research and development of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; conducting clinical trials of others in the field of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; medical, biological, and scientific research relating to the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases, in particular via immunotherapy
Additional Information
Pseudo Mark
HER VOLUTION
Classification
International Classes
005
035
042